Medistep Healthcare IPO: GMP at 40%, Issue Size at Rs 16.10 Cr, and Listing Expected on Aug 18
PorAinvest
jueves, 7 de agosto de 2025, 10:20 pm ET1 min de lectura
HNI--
The company has generated significant market interest, with the grey market premium (GMP) surging to 40% over the issue price. This surge indicates strong investor appetite and potential for upside on debut. The grey market premium has reached Rs 17, implying an implied listing price of around Rs 60 per share [1].
Medistep Healthcare specializes in manufacturing and trading a range of products, including sanitary pads (DryStep brand), energy powder (VitaStep Z), nutraceuticals, pharmaceuticals, and intimate and surgical products. The company aims to scale its manufacturing and trading verticals post-listing [1].
The IPO comprises a 100% fresh issue of 37.44 lakh equity shares, with no offer for sale component. The issue is being led by Fast Track Finsec as the book-running lead manager, while Cameo Corporate Services is the registrar [1].
Medistep Healthcare reported revenues of Rs 49.66 crore in FY25, a 27% year-over-year (YoY) increase, with PAT at Rs 4.14 crore, up 25%. The company intends to use IPO proceeds to fund plant and machinery purchases, meet working capital needs (Rs 12.34 crore), and for general corporate purposes [1].
The IPO is a Fixed Price Issue, with a price band of Rs 43 per share. The retail quota is 50%, QIB is 0%, and HNI is 50%. The IPO listing is scheduled on the NSE SME platform [2].
References:
[1] https://m.economictimes.com/markets/ipos/fpos/medistep-healthcare-ipo-opens-today-check-gmp-issue-size-price-band-and-other-details/amp_articleshow/123178126.cms
[2] https://ipowatch.in/medistep-healthcare-ipo-date-review-price-allotment-details/
Medistep Healthcare, an Ahmedabad-based pharmaceutical and wellness products company, is set to open its Rs 16.10 crore IPO on August 8, with the issue closing on August 12. The issue price is fixed at Rs 43 per share, and shares are scheduled to list on August 18, 2025. The grey market premium has surged to 40% over the issue price, signalling strong investor appetite and potential for upside on debut. The company plans to use IPO proceeds to fund plant and machinery purchases, meet working capital needs, and for general corporate purposes.
Medistep Healthcare, an Ahmedabad-based pharmaceutical and wellness products company, is set to open its Rs 16.10 crore Initial Public Offering (IPO) on August 8, with the issue closing on August 12. The issue price is fixed at Rs 43 per share, and shares are scheduled to list on August 18, 2025 [1].The company has generated significant market interest, with the grey market premium (GMP) surging to 40% over the issue price. This surge indicates strong investor appetite and potential for upside on debut. The grey market premium has reached Rs 17, implying an implied listing price of around Rs 60 per share [1].
Medistep Healthcare specializes in manufacturing and trading a range of products, including sanitary pads (DryStep brand), energy powder (VitaStep Z), nutraceuticals, pharmaceuticals, and intimate and surgical products. The company aims to scale its manufacturing and trading verticals post-listing [1].
The IPO comprises a 100% fresh issue of 37.44 lakh equity shares, with no offer for sale component. The issue is being led by Fast Track Finsec as the book-running lead manager, while Cameo Corporate Services is the registrar [1].
Medistep Healthcare reported revenues of Rs 49.66 crore in FY25, a 27% year-over-year (YoY) increase, with PAT at Rs 4.14 crore, up 25%. The company intends to use IPO proceeds to fund plant and machinery purchases, meet working capital needs (Rs 12.34 crore), and for general corporate purposes [1].
The IPO is a Fixed Price Issue, with a price band of Rs 43 per share. The retail quota is 50%, QIB is 0%, and HNI is 50%. The IPO listing is scheduled on the NSE SME platform [2].
References:
[1] https://m.economictimes.com/markets/ipos/fpos/medistep-healthcare-ipo-opens-today-check-gmp-issue-size-price-band-and-other-details/amp_articleshow/123178126.cms
[2] https://ipowatch.in/medistep-healthcare-ipo-date-review-price-allotment-details/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios